-
Presence & voting results
Here you will find the presence and voting results at the AGM 2026.
Read more -
Speech by the CEO
Speech by Belén Garijo, Chair of the Executive Board and CEO.
Read the Speech
Select your Market
-
{{ userContent.title }}
{{ userContent.lookingForMoreLabel }}
Annual General Meeting 2026
Annual General Meeting 2026
Merck KGaA, Darmstadt, Germany held its 31st Annual General Meeting as in-person event on April 24, 2026 in Frankfurt-Höchst (Germany). All of the resolutions on the agenda were approved, including the dividend of € 2.20 per share.
Documents and further information for the AGM 2026
| Download | ||
|---|---|---|
| Convening Notice of the Annual General Meeting of Merck KGaA, Darmstadt, Germany, on April 24 2026 | ||
| Speech by Belén Garijo, Chair of the Executive Board and CEO of Merck KGaA, Darmstadt, Germany (preliminary preview version as of April 16, 2026) | ||
| Presence and Voting Results | ||
| Dividend announcement | ||
| Information in accordance with Table 8 of the Regulation (EU) 2018/1212 (Dividend) | ||
| Explanation of Shareholder Rights | ||
| Information on Data Privacy for Shareholders | ||
| Form for proxies and exercising voting rights | ||
| Organizational information AGM | ||
| Technical Directions for the Investor Portal | PDF | |
| Document in accordance with Section 125 of the German Stock Corporation Act (AktG) in conjunction with Implementing Regulation (EU) 2018/1212 (GOR) | ||
| Annual report of Merck KGaA, Darmstadt, Germany for the fiscal year 2025 including the consolidated financial statements, combined Management report and Supervisory Board report | ||
| Single entity financial statements of Merck KGaA, Darmstadt, Germany for the fiscal year 2025 including the combined Management report | ||
| Compensation Report 2025 |